Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-EN Version v10-EN
Language English English
Date Updated 2017-07-15 2017-06-09
Drug Identification Number 02223406 02223406
Brand name INTRON A INTRON A
Common or Proper name interferon alfa-2b lyophilized powder interferon alfa-2b lyophilized powder
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients WATER INTERFERON ALFA-2B WATER INTERFERON ALFA-2B
Strength(s) 1ML 10000000UNIT 1ML 10000000UNIT
Dosage form(s) LIQUID POWDER FOR SOLUTION LIQUID POWDER FOR SOLUTION
Route of administration INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1X10 MIU 1X10 MIU
ATC code L03AB L03AB
ATC description IMMUNOSTIMULANTS IMMUNOSTIMULANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-05-03 2017-05-03
Actual start date 2017-05-03 2017-05-03
Estimated end date 2017-07-21 2017-06-09
Actual end date 2017-07-14 2017-06-09
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Limited quantities will be available Limited quantities will be available
Health Canada comments